Polymeric Biomaterials Market (2026 - 2033)

Polymeric Biomaterials Market Summary

The global polymeric biomaterials market size was valued at USD 69.1 billion in 2025 and is projected to grow from USD 80.5 billion in 2026 to USD 237.4 billion by 2033, growing at a CAGR of 16.7% from 2026 to 2033. North America dominated the market, accounting for the largest global share of 37.9% in 2025. Major factors driving market expansion include frequent innovations in polymeric biomaterials, growing applications of polymeric biomaterials in tissue engineering, a rising prevalence of chronic diseases, and a growing requirement for polymeric biomaterials in surgeries.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The COVID-19 pandemic adversely impacted the market owing to several lockdown hindrances in supply chain operations, and decreased clinical research activities. Despite these challenges, the market is expected to witness strong growth prospects in the long term due to an increasing adoption of polymeric biomaterials for devising new therapeutic strategies for COVID-19 treatment. For instance, according to an article published in the Emergent Materials Journal in April 2021, biomaterial substances were studied for the controlled delivery of drugs, such as interleukin 6 (IL-6) inhibitors, for COVID-19 treatment. As a result, with increasing demand for novel therapeutics for COVID-19, the market is expected to witness significant growth in the coming years.

Technologically advanced polymeric biomaterials are offering a promising solution to challenges faced by autologous or allograft-based treatments, such as shortage of donors, possible immune rejection, and size or modality mismatches. Polymeric artificial constructs that mimic structural and functional properties of the extracellular matrix show application in promoting cell growth. Moreover, several advanced polymeric substances are also being introduced to complement existing implant solutions and to improve their efficiency. For instance, in March 2022, Evonik expanded its offerings for 3D-printable biomaterials with the launch of its osteoconductive VESTAKEEP iC4800 3DF PEEK filament, which can improve the fusion between implants and bone. Such innovations are expected to expand the growth prospects for the polymeric biomaterial market.

To learn more about this report, Download Free Sample Report

According to the White House in September 2022, the Department of Energy had plans to announce USD 178 million for the advancement of innovative research in the area of bioproducts, biomaterials, and biotechnology. Increasing government support through funding and initiatives also contributes extensively to market growth. Additionally, increasing demand for biomaterials in several healthcare areas, for instance, 3D printing in medicine, tissue engineering, implants, biotechnology, diagnostic systems, nanomaterials, and bioimaging is anticipated to aid market expansion.

Market Dynamics

The polymeric biomaterials market is experiencing steady growth, driven by the increasing use of polymeric biomaterials in medical devices, drug delivery systems, tissue engineering, and regenerative medicine. Rising prevalence of chronic diseases, growing demand for minimally invasive procedures, advancements in polymer technologies, and increasing investments in biomedical research are further supporting market expansion. In addition, the growing focus on personalized medicine and the development of biocompatible and biodegradable materials are expected to drive market growth over the forecast period.

Analyst Perspective

The polymeric biomaterials market is expected to witness steady growth, driven by the increasing demand for implantable medical devices, prosthetics, tissue engineering products, and drug delivery systems. Rising prevalence of chronic diseases, growing aging populations, and expanding adoption of minimally invasive procedures are fueling the use of polymer-based biomaterials in healthcare applications. Continuous advancements in biodegradable and bioresorbable polymers, along with increasing investments in regenerative medicine and medical device innovation, are expected to support long-term market expansion. Market participants are focusing on developing high-performance, biocompatible materials to enhance patient outcomes and meet evolving clinical requirements.

Product Insights

Based on product, the market is segmented into Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polyurethanes, Polytetrafluoroethylene (PTFE) & expanded polytetrafluoroethylene (ePTFE), Polyaryletheretherketone (PEEK), Polydioxanone (PDO), and others. Based on product, the polylactic acid (PLA) segment held the largest revenue share of over 20.7% in 2025. The growth is attributed to the extensive application of PLA with fixation devices, such as dissolvable suture meshes and resorbable plates & screws, owing to the increasing preference for PLA over metallic implants. Furthermore, homopolymers in the PLA family, such as Poly-L-Lactic Acid (PLLA), have been widely studied to harness their mechanical properties and tailorable biodegradability.

The Polytetrafluoroethylene (PTFE) and expanded polytetrafluoroethylene (ePTFE) segment is anticipated to showcase the fastest CAGR of 25.2% over the forecast period. The rising demand for the treatment of non-self-containing bone defects and multi-walled defects in vertical augmentations is driving demand for polymeric biomaterials. Moreover, metallic stents for palliative treatment of unresectable malignant esophageal strictures are coated with PTFE introducer sheaths, which also contribute to its growth.

Application Insights

Based on application, the market is segmented into plastic surgery, dental, neurology, cardiovascular, orthopedic, and others. Based on application, the orthopedic segment held the largest revenue share of over 23.5% in 2025. The segment growth is attributed to the growing incidence of orthopedic diseases. As per Southeast Orthopedic Specialists, incidences arising due to orthopedic conditions are anticipated to rise in the U.S., aided by the growing geriatric population. As of June 2023, approximately 45 million adults who were 65 years of age and older were living in the country. This number is expected to rise to around 98 million by 2060. Additionally, osteoarthritis impacts 33.3% of the elderly population each year. Thus, the increasing incidence rates of such disorders are encouraging scientists to discover novel and more effective treatment options that are based on polymeric biomaterials.

To learn more about this report, Download Free Sample Report

The plastic surgery segment is anticipated to witness the fastest CAGR of 24.3% over the forecast period. The strong segment growth is on account of its extensive adoption in rhinoplasty, breast augmentation, and face lifts. A survey conducted by the International Society of Aesthetic Plastic Surgery found that approximately 365,000 breast augmentation surgeries were performed in 2021, which was a jump of 44% from the previous year. Moreover, around 148,000 women underwent implant replacement and implant removal surgeries in 2021.

Regional Insights

North America dominated the polymeric biomaterials market with the largest revenue share of 37.9% in 2025. The large share of this region is due to a rise in the number of surgical procedures for orthopedic injuries and cosmetic surgeries and the need for sustainable biomaterials in this region. Moreover, the presence of major market players involved in the manufacturing and development of innovative solutions for reconstructive surgical procedures is positively impacting the market. In addition, homegrown companies form strategic partnerships with each other as well as foreign-established enterprises to enhance their presence in the medical implants market, which in turn is expected to boost market growth in the coming years.

To learn more about this report, Download Free Sample Report

U.S. Polymeric Biomaterials Market Trends

The polymeric biomaterials market in the U.S. held the largest share in the North America region in 2025. 

Asia Pacific is anticipated to showcase the fastest CAGR of 21.5% over the forecast period. The regional growth is expected to be aided by an increasing demand for dental implants and a rising geriatric population. As per the Ministry of Health and Family Welfare, more than 60% of Indians presently suffer from dental cavities, while over 85% experience periodontal disorders. Moreover, oral cancer is considered to be an important health issue in India. Thus, an increasing prevalence of such conditions is expected to drive the regional market growth.

Key Companies & Market Share Insights

The increasing demand for polymeric biomaterial for various applications has resulted in numerous market opportunities for key players to capitalize on. Major players are adopting various strategies such as acquisitions, mergers, and collaborations to expand their market share.

Recent Developments

• In March 2023, Invibio Ltd launched its PEEK-OPTIMA AM filament, which has been optimized for additive manufacturing for medical devices.

• In February 2023, Victrex plc (Invibio Ltd.)expanded Invibio’s medical R&D and manufacturing capabilities by announcing the opening of a new product development facility in Leeds, UK.

• In January 2023, MicroPort Scientific Corporation received marketing approval for its Firehawk Liberty Rapamycin Target Eluting Coronary Stent System in Russia.

Global Polymeric Biomaterials Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global polymeric biomaterials market report based on product, application, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Polylactic Acid (PLA)

  • Polyglycolic Acid (PGA)

  • Polyurethanes

  • Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)

  • Polyaryletheretherketone (PEEK)

  • Polydioxanone (PDO)

  • Others

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Cardiovascular

    • Bioresorbable Stents

    • Vascular Grafts

    • Sensors

    • Guidewires

    • Implantable Cardiac Defibrillators

    • Pacemakers

    • Others

  • Dental

    • Tissue Regeneration Materials

    • Dental Implants

    • Bone Grafts & Substitutes

    • Dental Membranes

    • Dental Sutures

    • Others

  • Orthopedic

    • Joint Replacement Polymeric Biomaterials

    • Tissue Fixation Products

      • Suture Anchors

      • Others

    • Orthobiologics

    • Viscosupplementation

    • Spine Biomaterials

    • Others

  • Plastic Surgery

    • Facial Wrinkle Treatment

    • Soft Tissue Fillers

    • Craniofacial Surgery

      • Sutures

      • Others

    • Bioengineered Skins

    • Peripheral Nerve Repair

    • Acellular Dermal Matrices

    • Others

  • Neurology

    • Neural Stem Cell Encapsulation

    • Shunting Systems

    • Hydrogel Scaffold For CNS Repair

    • Cortical Neural Prosthetics

    • Others

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The polymeric biomaterials market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each polymeric biomaterials segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations